NEW YORK (GenomeWeb News) – Station X, a Redwood City, Calif.-based bioinformatics firm, has closed a second round of equity financing led by Runa Capital that included follow-on commitments from existing investors including Genomic Health.

The company said this week that it plans to use the $5 million raised in this round to expand its team and to push forward commercialization plans for GenePool, its software for storing, analyzing, and visualizing genomic data in translational research settings, diagnostic and pharmaceutical development, and clinical genome analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.